Molecular architecture of G protein‐coupled receptors
暂无分享,去创建一个
[1] M. Caron,et al. Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. , 1992, The Journal of biological chemistry.
[2] J. Wess,et al. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[3] M. Ascoli,et al. Mutation of a highly conserved acidic residue present in the second intracellular loop of G-protein-coupled receptors does not impair hormone binding or signal transduction of the luteinizing hormone/chorionic gonadotropin receptor. , 1993, Molecular endocrinology.
[4] R. Mark,et al. Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity. , 1992, The Journal of biological chemistry.
[5] G von Heijne,et al. Membrane proteins: from sequence to structure. , 1990, Protein engineering.
[6] B. Roth,et al. A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors. , 1993, Molecular pharmacology.
[7] J. Baldwin. The probable arrangement of the helices in G protein‐coupled receptors. , 1993, The EMBO journal.
[8] C. Strader,et al. Allele-specific activation of genetically engineered receptors. , 1991, The Journal of biological chemistry.
[9] C. M. Chen,et al. The role of the WSXWS equivalent motif in growth hormone receptor function. , 1994, The Journal of biological chemistry.
[10] M. Duggan,et al. Orphan seven transmembrane domain receptors: reversing pharmacology. , 1994, Trends in pharmacological sciences.
[11] T. Endo,et al. Disruption of the first extracellular loop of thyrotropin receptor prevents ligand binding. , 1994, Life sciences.
[12] H. Lester,et al. cDNA cloning of a serotonin 5-HT1C receptor by electrophysiological assays of mRNA-injected Xenopus oocytes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[13] A. Egloff,et al. Replacement of lysine‐181 by aspartic acid in the third transmembrane region of endothelin type B receptor reduces its affinity to endothelin peptides and sarafotoxin 6c without affecting G protein coupling , 1992, Journal of cellular biochemistry.
[14] M. Saji,et al. A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty. , 1995, The Journal of clinical endocrinology and metabolism.
[15] C. Fraser,et al. Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. , 1991, Molecular pharmacology.
[16] J. Linden,et al. Molecular cloning and characterization of the human A3 adenosine receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[17] B. Sommer,et al. The dopamine D2 receptor: two molecular forms generated by alternative splicing. , 1989, The EMBO journal.
[18] J. Schwartz,et al. Cloning and tissue expression of a rat histamine H2-receptor gene. , 1991, Biochemical and Biophysical Research Communications - BBRC.
[19] H. G. Khorana,et al. Light-stable rhodopsin. II. An opsin mutant (TRP-265----Phe) and a retinal analog with a nonisomerizable 11-cis configuration form a photostable chromophore. , 1992, The Journal of biological chemistry.
[20] Jonathan A Javitch,et al. Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method , 1995, Neuron.
[21] J. Wess,et al. Hydrophilic side chains in the third and seventh transmembrane helical domains of human A2A adenosine receptors are required for ligand recognition. , 1996, Molecular pharmacology.
[22] P. Albert. Molecular biology of the 5-HT1A receptor: Low-stringency cloning and eukaryotic expression , 1992, Journal of Chemical Neuroanatomy.
[23] L. Hunyady,et al. Critical Role of a Conserved Intramembrane Tyrosine Residue in Angiotensin II Receptor Activation (*) , 1995, The Journal of Biological Chemistry.
[24] S. Chaki,et al. Identification of amino acid residues of rat angiotensin II receptor for ligand binding by site directed mutagenesis. , 1992, Biochemical and biophysical research communications.
[25] P. Schofield,et al. A threonine residue in the seventh transmembrane domain of the human A1 adenosine receptor mediates specific agonist binding. , 1994, The Journal of biological chemistry.
[26] C. Strader,et al. Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function. , 1988, The Journal of biological chemistry.
[27] S. Nakanishi,et al. Cloning and expression of a cDNA encoding an endothelin receptor , 1990, Nature.
[28] R. Straub,et al. Expression cloning of a cDNA encoding the mouse pituitary thyrotropin-releasing hormone receptor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Nakai,et al. Location of a region of the muscarinic acetylcholine receptor involved in selective effector coupling , 1988, FEBS letters.
[30] G. FitzGerald,et al. Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites. , 1993, Molecular pharmacology.
[31] R. Osman,et al. Distinct roles for arginines in transmembrane helices 6 and 7 of the thyrotropin-releasing hormone receptor. , 1995, Molecular pharmacology.
[32] P. Corvol,et al. Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[33] A. Ashkenazi,et al. Distinct primary structures, ligand‐binding properties and tissue‐specific expression of four human muscarinic acetylcholine receptors. , 1987, The EMBO journal.
[34] J. Nathans,et al. Isolation, sequence analysis, and intron-exon arrangement of the gene encoding bovine rhodopsin , 1983, Cell.
[35] C. Strader,et al. Mapping the ligand binding site of the NK-1 receptor , 1993, Regulatory Peptides.
[36] J. Lowe,et al. Specific residues at the top of transmembrane segment V and VI of the neurokinin-1 receptor involved in binding of the nonpeptide antagonist CP 96,345 [corrected]. , 1994, The Journal of biological chemistry.
[37] S. Vishveshwara,et al. Geometry of proline-containing alpha-helices in proteins. , 2009, International journal of peptide and protein research.
[38] D. Oxender,et al. Identification of methionine134 and alanine146 in the second transmembrane segment of the human tachykinin NK3 receptor as reduces involved in species-selective binding to SR 48968. , 1994, Biochemical and biophysical research communications.
[39] R. Shigemoto,et al. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide , 1992, Neuron.
[40] B. Roth,et al. Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors. , 1992, Molecular pharmacology.
[41] T. Satoh,et al. Analysis of the TSH receptor gene structure in various thyroid disorders: DNA from thyroid adenomas can have large insertions or deletions. , 1992, Thyroid : official journal of the American Thyroid Association.
[42] D. Bichet,et al. Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant. , 1994, Cellular and molecular biology.
[43] D. Oprian,et al. Mechanism of activation and inactivation of opsin: role of Glu113 and Lys296. , 1992, Biochemistry.
[44] Takao Shimizu,et al. Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung , 1991, Nature.
[45] K. Jacobson,et al. Identification of an adenosine receptor domain specifically involved in binding of 5'-substituted adenosine agonists. , 1994, The Journal of biological chemistry.
[46] J Hoflack,et al. Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. , 1991, Molecular pharmacology.
[47] K. Livak,et al. Variability of dopamine D4 receptor (DRD4) gene sequence within and among nonhuman primate species. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[48] J. Wess,et al. Site-directed Mutagenesis Identifies Residues Involved in Ligand Recognition in the Human A2a Adenosine Receptor (*) , 1995, The Journal of Biological Chemistry.
[49] R. Paschke,et al. Importance of the extracellular domain of the human thyrotrophin receptor for activation of cyclic AMP production. , 1994, Journal of Molecular Endocrinology.
[50] J. Lowe,et al. Molecular basis for the species selectivity of the substance P antagonist CP-96,345. , 1993, The Journal of biological chemistry.
[51] T L Blundell,et al. The evolution and structure of aminergic G protein-coupled receptors. , 1994, Receptors & channels.
[52] R. Alexander,et al. Molecular cloning of AT1 angiotensin receptors. , 1992, American journal of hypertension.
[53] M. Mishina,et al. Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor , 1986, Nature.
[54] S. Kaushal,et al. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. , 1994, Biochemistry.
[55] C. Strader,et al. Molecular basis for the species selectivity of the neurokinin-1 receptor antagonists CP-96,345 and RP67580. , 1992, The Journal of biological chemistry.
[56] J. Harrison,et al. cDNA cloning of a G-protein-coupled receptor expressed in rat spinal cord and brain related to chemokine receptors , 1994, Neuroscience Letters.
[57] S. Narumiya,et al. Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder. , 1994, The Journal of clinical investigation.
[58] J. Hénichart,et al. Pharmacological and functional characterisation of the wild-type and site-directed mutants of the human H1 histamine receptor stably expressed in CHO cells. , 1995, Journal of receptor and signal transduction research.
[59] M. Caron,et al. An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins , 1987, Nature.
[60] B. Fredholm. Purinoceptors in the nervous system. , 1995, Pharmacology & toxicology.
[61] K. Jakobs,et al. Deletion analysis of the m4 muscarinic acetylcholine receptor. Molecular determinants for activation of but not coupling to the Gi guanine-nucleotide-binding regulatory protein regulate receptor internalization. , 1994, European journal of biochemistry.
[62] S. Coughlin. Expanding horizons for receptors coupled to G proteins: diversity and disease. , 1994, Current opinion in cell biology.
[63] J. Venter,et al. Cloning, localization, and permanent expression of a Drosophila octopamine receptor , 1990, Neuron.
[64] C. Slaughter,et al. The catecholamine binding site of the beta-adrenergic receptor is formed by juxtaposed membrane-spanning domains. , 1988, The Journal of biological chemistry.
[65] S Schiffmann,et al. RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. , 1990, Biochemical and biophysical research communications.
[66] D. Kunz,et al. The human leukocyte platelet-activating factor receptor. cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog. , 1992, The Journal of biological chemistry.
[67] K. Arai,et al. GPA1, a haploid-specific essential gene, encodes a yeast homolog of mammalian G protein which may be involved in mating factor signal transduction , 1987, Cell.
[68] W. C. Probst,et al. Sequence alignment of the G-protein coupled receptor superfamily. , 1992, DNA and cell biology.
[69] C. Gerfen,et al. Multiple D2 dopamine receptors produced by alternative RNA splicing , 1989, Nature.
[70] M. Freeman,et al. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. , 1991, Science.
[71] R. Osman,et al. A model of the thyrotropin-releasing hormone (TRH) receptor binding pocket. Evidence for a second direct interaction between transmembrane helix 3 and TRH. , 1994, The Journal of biological chemistry.
[72] M. Belfort,et al. Mechanisms of Intron Mobility (*) , 1995, The Journal of Biological Chemistry.
[73] K. Lynch,et al. RTA, a candidate G protein-coupled receptor: cloning, sequencing, and tissue distribution. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[74] D. Diviani,et al. Truncation of the receptor carboxyl terminus impairs agonist-dependent phosphorylation and desensitization of the alpha 1B-adrenergic receptor. , 1994, The Journal of biological chemistry.
[75] I Simon,et al. New alignment strategy for transmembrane proteins. , 1994, Journal of molecular biology.
[76] N. Birdsall. Cloning and structure-function of the H2 histamine receptor. , 1991, Trends in pharmacological sciences.
[77] J. Venter,et al. Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. , 1989, Molecular pharmacology.
[78] K. Jacobson,et al. Modelling the P2Y purinoceptor using rhodopsin as template. , 1995, Drug design and discovery.
[79] J. T. Turner,et al. Site-directed Mutagenesis of P2U Purinoceptors , 1995, The Journal of Biological Chemistry.
[80] N. Bunnett,et al. Characterization of antibodies to the rat substance P (NK-1) receptor and to a chimeric substance P receptor expressed in mammalian cells , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[81] M. Caron,et al. Site-directed mutagenesis of the cytoplasmic domains of the human beta 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling. , 1988, The Journal of biological chemistry.
[82] A. Kopin,et al. A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists , 1993, Nature.
[83] Y. Fukada,et al. What makes red visual pigments red? A resonance Raman microprobe study of retinal chromophore structure in iodopsin. , 1994, Biochemistry.
[84] R. Paschke,et al. Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. , 1994, The Journal of clinical endocrinology and metabolism.
[85] M. Caron,et al. Role of extracellular disulfide-bonded cysteines in the ligand binding function of the beta 2-adrenergic receptor. , 1990, Biochemistry.
[86] J. Wess,et al. Functional role in ligand binding and receptor activation of an asparagine residue present in the sixth transmembrane domain of all muscarinic acetylcholine receptors. , 1994, The Journal of biological chemistry.
[87] E. B. Hart,et al. COMPARATIVE EFFICIENCY FOR GROWTH OF THE TOTAL NITROGEN FROM ALFALFA HAY AND CORN GRAIN , 1912 .
[88] B. Kobilka,et al. Amino acid substitutions at position 312 in the seventh hydrophobic segment of the beta 2-adrenergic receptor modify ligand-binding specificity. , 1993, Molecular pharmacology.
[89] C. Strader,et al. Amino–aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345 , 1993, Nature.
[90] R. Lefkowitz,et al. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.
[91] Hong Wang,et al. Site-directed anti-peptide antibodies define the topography of the beta-adrenergic receptor. , 1989, The Journal of biological chemistry.
[92] Adriaan P. IJzerman,et al. Relative binding orientations of adenosine A1 receptor ligands — A test case for Distributed Multipole Analysis in medicinal chemistry , 1995, J. Comput. Aided Mol. Des..
[93] M. Caron,et al. High affinity agonist binding to the dopamine D3 receptor: chimeric receptors delineate a role for intracellular domains. , 1994, Molecular pharmacology.
[94] S. Loche,et al. Mutations in the vasopressin V2-receptor gene in three families of Italian descent with nephrogenic diabetes insipidus. , 1994, Human molecular genetics.
[95] J. Venter,et al. Site-directed mutagenesis of human beta-adrenergic receptors: substitution of aspartic acid-130 by asparagine produces a receptor with high-affinity agonist binding that is uncoupled from adenylate cyclase. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[96] C. Strader,et al. Identification of residues required for ligand binding to the beta-adrenergic receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[97] E. Sausville,et al. Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. , 1991, The Journal of biological chemistry.
[98] E. Hulme,et al. Muscarinic acetylcholine receptors. Peptide sequencing identifies residues involved in antagonist binding and disulfide bond formation. , 1990, The Journal of biological chemistry.
[99] A. Tucker,et al. A1 adenosine receptors. Two amino acids are responsible for species differences in ligand recognition. , 1994, The Journal of biological chemistry.
[100] J. Krause,et al. The roles of the putative third cytoplasmic loop and cytoplasmic carboxyl tail of NK-1 and NK-2 receptors in agonist stimulated second messenger responses in stably transfected CHO cells , 1993, Regulatory Peptides.
[101] R. H. Hilderman,et al. Identification of a serine protease which activates the mouse heart adenosine 5',5"',P1,P4-tetraphosphate receptor. , 1993, Biochemistry.
[102] H. Ladinsky,et al. The orphan receptor cDNA RDC4 encodes a 5-HT1D serotonin receptor. , 1991, Biochemical and biophysical research communications.
[103] H. Akil,et al. Cloning and characterization of a pharmacologically distinct A1 adenosine receptor from guinea pig brain. , 1994, Brain research. Molecular brain research.
[104] M. Mortrud,et al. Cloning and Functional Characterization of a Family of Receptors for the Melanotropic Peptides , 1993, Annals of the New York Academy of Sciences.
[105] R. Lefkowitz,et al. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.
[106] C. Azuma,et al. Molecular cloning of a human oxytocin receptor , 1993, Regulatory Peptides.
[107] T. Bonner,et al. Identification of a family of muscarinic acetylcholine receptor genes. , 1987, Science.
[108] H. Khorana,et al. Structure and function in rhodopsin. Studies of the interaction between the rhodopsin cytoplasmic domain and transducin. , 1992, The Journal of biological chemistry.
[109] W. Sadee,et al. Serine- and threonine-rich domain regulates internalization of muscarinic cholinergic receptors. , 1993, The Journal of biological chemistry.
[110] Marina Cocchi,et al. Quantitative structure-affinity/selectivity relationship analysis on three-dimensional models of the complexes between the ETA and ETB receptors and C-terminal endothelin hexapeptide antagonists , 1995 .
[111] E. Kieff,et al. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors , 1993, Journal of virology.
[112] J. Linden. Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions. , 1994, Trends in pharmacological sciences.
[113] Gunnar von Heijne,et al. Proline kinks in transmembrane α-helices☆ , 1991 .
[114] J. Wess,et al. Role of conserved threonine and tyrosine residues in acetylcholine binding and muscarinic receptor activation. A study with m3 muscarinic receptor point mutants. , 1992, The Journal of biological chemistry.
[115] D. Julius,et al. Expression cloning of an ATP receptor from mouse neuroblastoma cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[116] K. Neve,et al. Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction. , 1994, The Journal of biological chemistry.
[117] J. Nielsen,et al. Cytoplasmic sequences of the growth hormone receptor necessary for signal transduction. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[118] J. Nadeau,et al. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function , 1993, Cell.
[119] S. Kosugi,et al. The third exoplasmic loop of the thyrotropin receptor is partially involved in signal transduction , 1994, FEBS letters.
[120] J. Wess,et al. Insertion mutagenesis as a tool to predict the secondary structure of a muscarinic receptor domain determining specificity of G-protein coupling. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[121] M. Hanley,et al. Attenuation of agonist‐induced desensitization of the rat substance P receptor by progressive truncation of the C‐terminus , 1994, FEBS letters.
[122] H. Matsubara,et al. Two novel mutations in the vasopressin V2 receptor gene in unrelated Japanese kindreds with nephrogenic diabetes insipidus. , 1993, Biochemical and biophysical research communications.
[123] S. Souza,et al. A 40-Amino Acid Segment of the Growth Hormone Receptor Cytoplasmic Domain Is Essential for GH-induced Tyrosine-phosphorylated Cytosolic Proteins (*) , 1995, The Journal of Biological Chemistry.
[124] A. Rashtchian,et al. Novel methods for cloning and engineering genes using the polymerase chain reaction. , 1995, Current opinion in biotechnology.
[125] David Julius,et al. Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors , 1995, Nature.
[126] W. Greenlee,et al. Non-peptide Angiotensin Agonist , 1995, The Journal of Biological Chemistry.
[127] J. Richardson,et al. Amino acid preferences for specific locations at the ends of alpha helices. , 1988, Science.
[128] C. Fraser,et al. Cross-talk between m1 muscarinic acetylcholine and beta 2-adrenergic receptors. cAMP and the third intracellular loop of m1 muscarinic receptors confer heterologous regulation. , 1993, The Journal of biological chemistry.
[129] S. Chaki,et al. Cloning, expression and regulation of angiotensin II receptors. , 1992, Advances in experimental medicine and biology.
[130] J. Wess,et al. Functional role of proline and tryptophan residues highly conserved among G protein‐coupled receptors studied by mutational analysis of the m3 muscarinic receptor. , 1993, The EMBO journal.
[131] K. Fahmy,et al. Photoactivated state of rhodopsin and how it can form. , 1995, Biophysical chemistry.
[132] J. Parma,et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas , 1993, Nature.
[133] J. Wess,et al. Site‐directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding. , 1991, The EMBO journal.
[134] S. Nakanishi,et al. Molecular characterization of a functional cDNA for rat substance P receptor. , 1989, The Journal of biological chemistry.
[135] J. Wess,et al. Identification of an intracellular tyrosine residue critical for muscarinic receptor-mediated stimulation of phosphatidylinositol hydrolysis. , 1994, The Journal of biological chemistry.
[136] R. Leurs,et al. Site-directed mutagenesis of the histamine H1-receptor reveals a selective interaction of asparagine207 with subclasses of H1-receptor agonists. , 1994, Biochemical and biophysical research communications.
[137] Soma Das,et al. Mutations in the V2 vasopressin receptor gene are associated with X–linked nephrogenic diabetes insipidus , 1992, Nature Genetics.
[138] J. Baldwin,et al. Structure and function of receptors coupled to G proteins. , 1994, Current opinion in cell biology.
[139] K. Befort,et al. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[140] J. T. Turner,et al. Cloning, Expression, and Chromosomal Localization of the Human Uridine Nucleotide Receptor Gene (*) , 1995, The Journal of Biological Chemistry.
[141] H. Kao,et al. Site‐directed mutagenesis of a single residue changes the binding properties of the serotonin 5‐HT2 receptor from a human to a rat pharmacology , 1992, FEBS letters.
[142] T. Reisine,et al. Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein association. , 1993, Molecular pharmacology.
[143] C. Strader,et al. Interaction of glutamine 165 in the fourth transmembrane segment of the human neurokinin-1 receptor with quinuclidine antagonists. , 1994, The Journal of biological chemistry.
[144] R. Jensen,et al. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[145] T. Endo,et al. Point mutations in the thyrotropin receptor in human thyroid tumors. , 1995, Thyroid : official journal of the American Thyroid Association.
[146] D. Oprian,et al. Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness , 1993, Nature Genetics.
[147] K. Jacobson,et al. Molecular modeling of adenosine receptors. I. The ligand binding site on the A1 receptor. , 1992, Drug design and discovery.
[148] T. Sakmar,et al. Movement of the retinylidene Schiff base counterion in rhodopsin by one helix turn reverses the pH dependence of the metarhodopsin I to metarhodopsin II transition. , 1993, The Journal of biological chemistry.
[149] H Hayashi,et al. Site-directed mutagenesis of the histamine H1 receptor: roles of aspartic acid107, asparagine198 and threonine194. , 1994, Biochemical and biophysical research communications.
[150] E. Ross,et al. Chimeric muscarinic cholinergic:beta-adrenergic receptors that are functionally promiscuous among G proteins. , 1994, The Journal of biological chemistry.
[151] R. Dixon,et al. Sequence of the gene encoding the human M1 muscarinic acetylcholine receptor. , 1987, Nucleic acids research.
[152] T. Dryja,et al. Constitutive activation of phototransduction by K296E opsin is not a cause of photoreceptor degeneration. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[153] R. Mackenzie,et al. A D1/D2 chimeric dopamine receptor mediates a D1 response to a D2‐selective agonist , 1993, FEBS letters.
[154] J Hoflack,et al. Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. , 1992, Journal of medicinal chemistry.
[155] T. Minegishi,et al. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty , 1993, Nature.
[156] K. Mullis,et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.
[157] M. Uhler,et al. Molecular cloning of a gene encoding the histamine H2 receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[158] J. Ballesteros,et al. [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .
[159] E. Prossnitz,et al. Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. , 1991, Biochemical and biophysical research communications.
[160] P. Devreotes,et al. A chemoattractant receptor controls development in Dictyostelium discoideum. , 1988, Science.
[161] K. Jacobson,et al. Cloning, expression, and characterization of the unique bovine A1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis. , 1992, The Journal of biological chemistry.
[162] C. Strader,et al. Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor. , 1989, The Journal of biological chemistry.
[163] S. Green,et al. Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. , 1995, The Journal of clinical investigation.
[164] B. Kobilka,et al. A point mutation in the seventh hydrophobic domain of the alpha 2 adrenergic receptor increases its affinity for a family of beta receptor antagonists. , 1991, The Journal of biological chemistry.
[165] A. Shenker,et al. Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor , 1994, FEBS letters.
[166] L. Blomberg,et al. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[167] K. Page,et al. The functional role of the binding site aspartate in muscarinic acetylcholine receptors, probed by site-directed mutagenesis. , 1995, European journal of pharmacology.
[168] J Hoflack,et al. Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor. , 1995, The EMBO journal.
[169] T. Endo,et al. Desensitization and internalization of a thyrotrophin receptor lacking the cytoplasmic carboxy-terminal region. , 1994, Journal of molecular endocrinology.
[170] D. Cerretti,et al. Molecular characterization of the interleukin-8 receptor. , 1991, Biochemical and biophysical research communications.
[171] D. Donnelly,et al. The ligand binding site of the neurokinin 2 receptor. Site-directed mutagenesis and identification of neurokinin A binding residues in the human neurokinin 2 receptor. , 1996, The Journal of Biological Chemistry.
[172] N. Pollock,et al. Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation. , 1992, The Journal of biological chemistry.
[173] Y. Horio,et al. Expression cloning of a cDNA encoding the bovine histamine H1 receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[174] T. Schwartz,et al. Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding. , 1994, The Journal of biological chemistry.
[175] T. Ji,et al. Asp383 in the second transmembrane domain of the lutropin receptor is important for high affinity hormone binding and cAMP production. , 1991, The Journal of biological chemistry.
[176] V. Wheaton,et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.
[177] G. Stiles,et al. Posttranscriptional mRNA processing as a mechanism for regulation of human A1 adenosine receptor expression. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[178] Intramolecular interactions in muscarinic acetylcholine receptors studied with chimeric m2/m5 receptors. , 1994, Molecular pharmacology.
[179] M. Brann,et al. Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions. , 1993, Molecular pharmacology.
[180] M. Caron,et al. The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptor , 1988, Nature.
[181] D. Oprian,et al. Effect of carboxylic acid side chains on the absorption maximum of visual pigments. , 1989, Science.
[182] D. Donnelly,et al. Seven-helix receptors: structure and modelling , 1994 .
[183] G. Mcallister,et al. Characterisation of a chimeric hD3/D2 dopamine receptor expressed in CHO cells , 1993, FEBS letters.
[184] M. Birnbaumer,et al. Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase. , 1993, The Journal of biological chemistry.
[185] Y. Sugimoto,et al. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. , 1993, The Journal of biological chemistry.
[186] M. Gregory,et al. X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. , 1993, The Journal of clinical investigation.
[187] B. Kobilka,et al. Identification of a single amino acid residue responsible for the binding of a class of beta-adrenergic receptor antagonists to 5-hydroxytryptamine1A receptors. , 1992, Molecular pharmacology.
[188] T. Sakmar,et al. Introduction of hydroxyl-bearing amino acids causes bathochromic spectral shifts in rhodopsin. Amino acid substitutions responsible for red-green color pigment spectral tuning. , 1992, The Journal of biological chemistry.
[189] T. Sakmar,et al. Characterization of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Mutations on the cytoplasmic surface affect transducin activation. , 1993, The Journal of biological chemistry.
[190] Gert Vriend,et al. A common motif in G-protein-coupled seven transmembrane helix receptors , 1993, J. Comput. Aided Mol. Des..
[191] H. Khorana,et al. Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[192] M. Parmentier,et al. The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor. , 1991, The EMBO journal.
[193] Kolakowski Lf. GCRDB: A G-PROTEIN-COUPLED RECEPTOR DATABASE , 1994 .
[194] E. Mutschler,et al. Functional role of a cytoplasmic aromatic amino acid in muscarinic receptor-mediated activation of phospholipase C. , 1994, The Journal of biological chemistry.
[195] Yoshihisa Inoue,et al. Mutagenesis and the Molecular Modeling of the Rat Angiotensin II Receptor (AT1) (*) , 1995, The Journal of Biological Chemistry.
[196] W. Greenlee,et al. Identification of peptide binding residues in the extracellular domains of the AT1 receptor. , 1994, The Journal of biological chemistry.
[197] C. Strader,et al. The role of histidine 265 in antagonist binding to the neurokinin-1 receptor. , 1994, The Journal of biological chemistry.
[198] G. Baldwin,et al. The seventh transmembrane domain of gastrin/CCK receptors contributes to non-peptide antagonist binding. , 1994, Biochemical and biophysical research communications.
[199] T. Schwartz,et al. Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor , 1995, Nature.
[200] R. Lefkowitz,et al. Constitutively active mutants of the alpha 2-adrenergic receptor. , 1993, The Journal of biological chemistry.
[201] H. Tai,et al. Expression and site-directed mutagenesis of mouse prostaglandin E2 receptor EP3 subtype in insect cells. , 1995, The Biochemical journal.
[202] R. Doolittle,et al. A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.
[203] K. Jarnagin,et al. Expression cloning of a rat B2 bradykinin receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[204] R. Lefkowitz,et al. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. , 1993, Trends in pharmacological sciences.
[205] R. Shapiro,et al. A deletion mutation in the third cytoplasmic loop of the mouse m1 muscarinic acetylcholine receptor unmasks cryptic G-protein binding sites. , 1993, The Journal of biological chemistry.
[206] D. Westfall,et al. Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization. , 1994, Pharmacological reviews.
[207] J. Nathans,et al. Histidine residues regulate the transition of photoexcited rhodopsin to its active conformation, metarhodopsin II , 1992, Neuron.
[208] M. Brann,et al. Structure-Function of Muscarinic Receptor Coupling to G Proteins , 1995, The Journal of Biological Chemistry.
[209] Brian K. Kobilka,et al. Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin , 1986, Nature.
[210] Yi-Jun Guo,et al. Molecular basis for the interaction of histamine with the histamine H2 receptor. , 1992, The Journal of biological chemistry.
[211] R A Gibbs,et al. Multiplex PCR: advantages, development, and applications. , 1994, PCR methods and applications.
[212] H. Lester,et al. The role of conserved aspartate and serine residues in ligand binding and in function of the 5‐HT1A receptor: A site‐directed mutation study , 1992, FEBS letters.
[213] J. Bockaert,et al. The metabotropic glutamate receptors: their second intracellular loop plays a critical role in the G-protein coupling specificity. , 1995, Biochemical Society transactions.
[214] J. Millán,et al. Gly114Asp mutation of rhodopsin in autosomal dominant retinitis pigmentosa. , 1995, Molecular and Cellular Probes.
[215] B. V. van Oost,et al. Inheritance of mutations in the V2 receptor gene in thirteen families with nephrogenic diabetes insipidus. , 1994, Kidney international.
[216] B. Ozenberger,et al. A single amino acid substitution in somatostatin receptor subtype 5 increases affinity for somatostatin-14. , 1995, Molecular pharmacology.
[217] J. Novotný,et al. Mutation of peptide binding site in transmembrane region of a G protein-coupled receptor accounts for endothelin receptor subtype selectivity. , 1994, The Journal of biological chemistry.
[218] L. Musgrove,et al. Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor. , 1992, Biochemical and biophysical research communications.
[219] T. Schwartz,et al. Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists. , 1993, The Journal of biological chemistry.
[220] K. Mullis,et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.
[221] G Burnstock,et al. Nomenclature and Classification of Purinoceptors* , 2005 .
[222] M. Ascoli,et al. The regulation of the binding affinity of the luteinizing hormone/choriogonadotropin receptor by sodium ions is mediated by a highly conserved aspartate located in the second transmembrane domain of G protein-coupled receptors. , 1993, Molecular endocrinology.
[223] E. Borrelli,et al. Alternative Splicing of the Dopamine D2 Receptor Directs Specificity of Coupling to G-proteins (*) , 1995, The Journal of Biological Chemistry.
[224] E M Brown,et al. Molecular Cloning and Functional Expression of Human Parathyroid Calcium Receptor cDNAs (*) , 1995, The Journal of Biological Chemistry.
[225] H. G. Khorana,et al. Palmitoylation of bovine opsin and its cysteine mutants in COS cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[226] S. Nakanishi,et al. Sequence and expression of a metabotropic glutamate receptor , 1991, Nature.
[227] G. Burnstock,et al. Cloning and functional expression of a brain G‐protein‐coupled ATP receptor , 1993, FEBS letters.
[228] T. Gallaher,et al. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation. , 1993, Molecular pharmacology.
[229] H. Khorana,et al. Structure and function in rhodopsin. Separation and characterization of the correctly folded and misfolded opsins produced on expression of an opsin mutant gene containing only the native intradiscal cysteine codons. , 1995, Biochemistry.
[230] C. Fraser,et al. Site-directed mutagenesis of the rat m1 muscarinic acetylcholine receptor. Role of conserved cysteines in receptor function. , 1992, The Journal of biological chemistry.
[231] T. Schwartz,et al. Conserved HisVI‐17 of the NK‐1 receptor is involved in binding of non‐peptide antagonists but not substance P , 1993, FEBS letters.
[232] S. Nakanishi,et al. Binding epitopes for peptide and non-peptide ligands on the NK1 (substance P) receptor , 1992, Regulatory Peptides.
[233] B. O'dowd,et al. A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors , 1992, Nature.
[234] E. Emini,et al. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide , 1985, Journal of virology.
[235] G. Dorn,et al. Cloning and pharmacologic characterization of a thromboxane A2 receptor from K562 (human chronic myelogenous leukemia) cells. , 1994, The Journal of pharmacology and experimental therapeutics.
[236] M. Caron,et al. Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. , 1988, Science.
[237] W. Meyerhof,et al. Cloning of a cDNA encoding a novel putative G-protein-coupled receptor expressed in specific rat brain regions. , 1991, DNA and cell biology.
[238] T. Schwartz,et al. The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors. , 1994, Molecular pharmacology.
[239] STE2 protein of Saccharomyces kluyveri is a member of the rhodopsin/beta-adrenergic receptor family and is responsible for recognition of the peptide ligand alpha factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[240] S. Fuchs,et al. In vitro translation of D2 dopamine receptors and their chimaeras: analysis by subtype-specific antibodies. , 1994, Biochemical and biophysical research communications.
[241] R. Osman,et al. Hydrogen bonding interaction of thyrotropin-releasing hormone (TRH) with transmembrane tyrosine 106 of the TRH receptor. , 1994, The Journal of biological chemistry.
[242] R. Henderson,et al. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. , 1990, Journal of molecular biology.
[243] B. Kobilka,et al. Antagonist-dependent and -independent steps in the mechanism of adrenergic receptor internalization. , 1994, The Journal of biological chemistry.
[244] C. Strader,et al. Structural features required for ligand binding to the beta‐adrenergic receptor. , 1987, The EMBO journal.
[245] R. Lefkowitz,et al. Identification of the cardiac beta-adrenergic receptor protein: solubilization and purification by affinity chromatography. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[246] C. Strader,et al. Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. , 1992, The Journal of biological chemistry.
[247] C. A. Guyer,et al. An aspartate conserved among G-protein receptors confers allosteric regulation of alpha 2-adrenergic receptors by sodium. , 1990, The Journal of biological chemistry.
[248] T. Schwartz,et al. Locating ligand-binding sites in 7TM receptors by protein engineering. , 1994, Current opinion in biotechnology.
[249] M. Caron,et al. Mutagenesis of the beta 2-adrenergic receptor: how structure elucidates function. , 1992, Annual review of pharmacology and toxicology.
[250] R. Bennett,et al. Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus. , 1994, American journal of human genetics.
[251] J. Navarro,et al. Molecular cloning of the fMet-Leu-Phe receptor from neutrophils. , 1990, The Journal of biological chemistry.
[252] A. Shenker,et al. Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies. , 1992, The Journal of biological chemistry.
[253] S. Liggett,et al. Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[254] C. Fraser. Site-directed mutagenesis of beta-adrenergic receptors. Identification of conserved cysteine residues that independently affect ligand binding and receptor activation. , 1989, The Journal of biological chemistry.
[255] M. Brownstein,et al. Molecular cloning and expression of rat V1a and V2 arginine vasopressin receptors , 1993, Regulatory Peptides.
[256] H. Khorana,et al. Resonance Raman microprobe spectroscopy of rhodopsin mutants: effect of substitutions in the third transmembrane helix. , 1992, Biochemistry.
[257] M. Birnbaumer,et al. An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system. , 1994, Molecular endocrinology.
[258] G. Barsh,et al. Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding. , 1992, Molecular pharmacology.
[259] H. Khorana,et al. Structure and function in rhodopsin: replacement by alanine of cysteine residues 110 and 187, components of a conserved disulfide bond in rhodopsin, affects the light-activated metarhodopsin II state. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[260] S. Yokoyama,et al. Rhodopsin from the fish, Astyanax: role of tyrosine 261 in the red shift. , 1995, Investigative ophthalmology & visual science.
[261] J. Venter,et al. Site-directed mutagenesis and continuous expression of human beta-adrenergic receptors. Identification of a conserved aspartate residue involved in agonist binding and receptor activation. , 1988, The Journal of biological chemistry.
[262] C. Strader,et al. Mutations that uncouple the beta-adrenergic receptor from Gs and increase agonist affinity. , 1987, The Journal of biological chemistry.
[263] R. Osman,et al. Thyrotropin-releasing hormone binding to the mouse pituitary receptor does not involve ionic interactions. A model for neutral peptide binding to G protein-coupled receptors. , 1992, The Journal of biological chemistry.
[264] J. Nathans,et al. Rhodopsin mutation proline347-to-alanine in a family with autosomal dominant retinitis pigmentosa indicates an important role for proline at position 347. , 1995, Human molecular genetics.
[265] S. Sealfon,et al. Molecular function of the gonadotropin-releasing hormone receptor: insights from site-directed mutagenesis , 1994, Molecular and Cellular Endocrinology.
[266] S. Snyder,et al. Cloning and expression of a rat somatostatin receptor enriched in brain. , 1992, The Journal of biological chemistry.
[267] N. Arnheim,et al. The polymerase chain reaction. , 1989, Trends in genetics : TIG.
[268] M. Gershengorn. Thyrotropin-releasing hormone receptor: cloning and regulation of its expression. , 1993, Recent progress in hormone research.
[269] E. Parker,et al. A Single Amino Acid Difference Accounts for the Pharmacological Distinctions Between the Rat and Human 5‐Hydroxytryptamine1B Receptors , 1993, Journal of neurochemistry.
[270] Paul H. J. Nederkoorn,et al. Modelling and mutation studies on the histamine H1-receptor agonist binding site reveal different binding modes for H1-agonists: Asp116 (TM3) has a constitutive role in receptor stimulation , 1995, J. Comput. Aided Mol. Des..
[271] C. Strader,et al. A single amino acid substitution in the beta-adrenergic receptor promotes partial agonist activity from antagonists. , 1989, The Journal of biological chemistry.
[272] M. Caron,et al. Cloning of the cDNA and genes for the hamster and human beta 2-adrenergic receptors. , 1988, Journal of receptor research.
[273] P. Goldman-Rakic,et al. Characterization of subtype-specific antibodies to the human D5 dopamine receptor: studies in primate brain and transfected mammalian cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[274] C. Strader,et al. Structure and function of G protein-coupled receptors. , 1994, Annual review of biochemistry.
[275] P. Sieving,et al. Disruption of conserved rhodopsin disulfide bond by Cys187Tyr mutation causes early and severe autosomal dominant retinitis pigmentosa. , 1995, Ophthalmology.
[276] E. Liu,et al. Aspartate mutation distinguishes ETA but not ETB receptor subtype‐selective ligand binding while abolishing phospholipase C activation in both receptors , 1995, FEBS letters.
[277] M. Houslay. G‐protein linked receptors: a family probed by molecular cloning and mutagenesis procedures , 1992, Clinical endocrinology.
[278] Mark Froimowitz,et al. Homology modeling of the dopamine D2 receptor and its testing by docking of agonists and tricyclic antagonists. , 1994, Journal of medicinal chemistry.
[279] H. Weinstein,et al. Polarity conserved positions in transmembrane domains of G‐protein coupled receptors and bacteriorhodopsin , 1994, FEBS letters.
[280] K. Neve,et al. Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase. , 1991, Molecular pharmacology.
[281] Gebhard F. X. Schertler,et al. Projection structure of rhodopsin , 1993, Nature.
[282] J. Wess,et al. Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors. , 1992, Molecular pharmacology.
[283] C. Barberis,et al. Expression cloning of the human V2 vasopressin receptor , 1993, Regulatory Peptides.
[284] K. Jacobson,et al. Role of the second extracellular loop of adenosine receptors in agonist and antagonist binding. Analysis of chimeric A1/A3 adenosine receptors. , 1994, The Journal of biological chemistry.
[285] J. Pouysségur,et al. Post-translational and Activation-dependent Modifications of the G Protein-coupled Thrombin Receptor (*) , 1995, The Journal of Biological Chemistry.
[286] L. E. Bockstahler. Overview of international PCR standardization efforts. , 1994, PCR methods and applications.
[287] R. Jensen,et al. The fifth transmembrane segment of the neuromedin B receptor is critical for high affinity neuromedin B binding. , 1993, The Journal of biological chemistry.
[288] C. Broger,et al. Separable binding sites for the natural agonist endothelin-1 and the non-peptide antagonist bosentan on human endothelin-A receptors. , 1995, European journal of biochemistry.
[289] K. Jacobson,et al. Adenosine A1 and A2 receptors: Structure–function relationships , 1992, Medicinal research reviews.
[290] D. Grandy,et al. Cloning and expression of a rat D2 dopamine receptor cDNA , 1988, Nature.
[291] G Vassart,et al. Selective amplification and cloning of four new members of the G protein-coupled receptor family. , 1989, Science.
[292] P. Prusis,et al. A three dimensional model for the interaction of MSH with the melanocortin-1 receptor. , 1995, Biochemical and biophysical research communications.
[293] J. Wess,et al. Identification of a small intracellular region of the muscarinic m3 receptor as a determinant of selective coupling to PI turnover , 1989, FEBS letters.
[294] D. Oprian,et al. Constitutively active mutants of rhodopsin , 1992, Neuron.
[295] H. Akil,et al. Site-directed mutagenesis of the human dopamine D2 receptor. , 1992, European journal of pharmacology.
[296] A. Surprenant,et al. A point mutation of the alpha 2-adrenoceptor that blocks coupling to potassium but not calcium currents. , 1992, Science.